Align Technology’s Bold India Bet Signals Next Phase of Global Growth

Align Technology Expands Manufacturing in India

Last week, ALGN announced plans to establish a new manufacturing facility in India in FY2027, with an investment of approximately $200 million over the coming years. Not only this announcement reflects the company’s strategy to get closer to its customers but also strengthen its supply chain resilience to boost shareholder value.

“India represents an important growth market for Align, and we are excited about the opportunity to expand our global manufacturing network with a new facility in Hyderabad,”

                                                  - Jitse Marrée, EVP Align Technology

Status Quo

ALGN currently operates three major manufacturing sites globally. Based on a regional hub manufacturing model, ALGN places production closer to customers in each major geographic market.

• Juárez, Mexico has been the company’s primary manufacturing base since the early 2000s and serves the North American and LATAM markets. Additionally, the company also operates Invisalign™ treatment-planning center in Costa Rica.

  
  

• FY2017 ALGN set up a new treatment planning facility in Chengdu, China. In addition to this, ALGN established its manufacturing base in Ziyang, Sichuan province during the same period. The manufacturing plant, which produces Invisalign™ clear aligners and iTero™ intraoral scanners, now serves as a primary production hub for the APAC region - primarily serving China, Australia, New Zealand, Malaysia, Singapore, Vietnam and other SEA countries.

  
  

• Wrocław, Poland became the company’s first EMEA manufacturing facility and its third Invisalign™ plant globally. The 80,000 m² manufacturing facility began operations in FY2022 and was designed to support EMEA demand with faster delivery and regional production capabilities. Additionally, the company operates Invisalign™ treatment-planning centers in Germany and Spain to serve its European customer base.

The Indian Manufacturing Challenge

As of today, every Invisalign™ case treated in the country requires treatment planning in India, fabrication in Juarez (Mexico), and ultimately shipment back to India — a significant logistics challenge that adds cost, complexity, delays and unfathomable supply chain risks. Especially amid ongoing tariff-related uncertainties and a challenging macroeconomic environment, Align Technology's decision to expand its manufacturing footprint into India is a strategic step toward geographic diversification. The initiative is expected to mitigate tariff exposure while strengthening the company's supply chain flexibility and operational resilience. The initiative offers a dual benefit: capturing growth opportunities in India's orthodontics market while fostering a more localized supply chain ecosystem and reducing exposure to import dependencies.

insightsZ estimates that the upcoming India-based manufacturing site can more efficiently serve SEA countries, MEA, and ANZ markets — reducing shipping distances and times across a combined patient population of >3 billion.

Local Tax Regulations: PLI Scheme

The Indian government has aggressively courted medical device manufacturers through the Production Linked Incentive (PLI) scheme, which provides 5% financial incentives on incremental manufacturing sales for 5 years. The flagship initiative is designed to reduce import dependence, encourage high-value manufacturing, and build a globally competitive medical devices industry in the country.

insightsZ estimates that ALGN's $200 million investment likely qualifies for significant PLI benefits, materially improving the economics of the facility in its first years of operation — consistent with the company's statement that the plant is expected to be margin accretive in year one. insightsZ estimates PLI scheme may enhance ALGN’s viability of Indian manufacturing project by helping offset initial costs and supporting business expansion.

The Indian Clear Aligner Market

The country’s clear aligner market remains one of the fastest-growing globally, expanding by +DD in FY2024 and +HSD in FY2025. This strong momentum contrasts with the slowdown observed in both the global and Chinese clear aligner markets over the same period.

India currently has more than 20 domestic clear aligner brands. Major leading domestic brands include Toothsi/makeO, Illusion Aligners, and Whistle (by Clove Dental) — offering treatment at 30-70% discount versus Invisalign’s ASP. These brands continue to gain market-share among mild-to-moderate cases, which represent most significant segment of the TAM. Let's have a look in more detail:

• MakeO/Toothsi, Invisalign’s leading domestic competitor, saw its FY2025 valuation ($124 Million) decline by 53% compared with its FY2024 valuation, potentially signalling weaker investor sentiment and a more challenging outlook for the country’s clear aligner industry. However, despite the valuation haircut, MakeO/Toothsi’s growth story in the country makes up enough evidence to warrant ALGN’s $200 million investment to scale its operations in the country.

  
  

• During FY2024 and FY2025, MakeO/Toothsi demonstrated a CAGR of approx. 48 percent. Earlier this year, MakeO/Toothsi even acquired Singapore-based clear aligner manufacturer Zenyum, which operates across Taiwan, Hong Kong, Japan, Singapore, Malaysia, Vietnam, Saudi Arabia, Qatar, and the UAE. The combined entity positions India as a strategic and manufacturing hub for aligner production across Asia, further underscoring the strength and maturation of the country’s manufacturing ecosystem.

  
  

• Other key competitors include Illusion™ Aligners – backed by the country’s largest manufacturing platform – Laxmi Dental (NSE: LAXMIDENTL). Another key player – Whistle™ Aligners is backed by the country’s largest DSO Clove Dental, which operates more than 400 dental offices nationwide. Our ongoing sentiment analysis study revealed that Whistle™ Aligners have recorded significant scores across multiple trust-related metrics, reflecting strong confidence among Indian consumers.

  
  

• Straumann Group’s ClearCorrect™ has established a presence in the Indian market; however, it has yet to achieve a substantial market share. Similarly, OrthoFX introduced its NiTime Aligners in FY2024, but the brand has not gained meaningful traction in the market to date. Both international brands are priced at 10-15% discount versus Invisalign’s ASP for similar treatment cases.

  
  

• The country has also witnessed the rise of dental laboratories and OEMs as preferred providers for private label clear aligner treatments – both for solo-offices as well as dental chains. Leading this category, India’s largest dental laboratory network, DentCare™ has emerged as the no.1 provider – although it continues to remain a very niche player with limited commercial success.

insightsZ continues to monitor the ongoing developments and plans to share its findings in the upcoming version of this report.

DISCLAIMER:

The content of this website is NOT an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. Although the content in the website articles has been taken from sources that are believed to be accurate, no warranty or representation is made by insightsZ as to its correctness, completeness, timeliness or accuracy. insightsZ does not assume or undertake any duty to advise any person or investor, and accept no liability whatsoever for any direct, indirect or consequential loss arising from or in connection with any use or reliance of this Information or anything contained in it. insightsZ is not a registered investment, tax or legal advisor or a broker/dealer.

How does insightsZ gather market data?

• insightsZ analyses data from a wide variety of resources incl. financial statements, market trends, market research surveys and industry reports.

• insightsZ engages with industry experts, attends conferences, and networks with professionals in the dental industry to get firsthand insights and perspectives on market developments.

• insightsZ also relies on social listening tools, share of search tools, and other search index tools. Additionally, we also monitor USFDA filings, information about product recalls, USPTO (US Patents and Trademarks Office) patent applications, EPO (European Patent Office) patent applications, CE applications, Premarket Notifications, Premarket Applications, GUDID registrations and other publicly available databases.

• insightsZ does NOT use any material non-public information that could lead to legal issues such as insider trading.

• Concerning market research interviews, we make sure that we follow the below mentioned guidelines and conduct expert interviews in a responsible and ethical manner:

• Clearly define the purpose of the interview: Before conducting the interview, we make sure that the expert understands the purpose of the discussion and that the focus is on gathering general insights and perspectives rather than specific, confidential information.

• Ask open-ended questions: insightsZ frames questions in a way that encourages the expert to share their knowledge and expertise without divulging sensitive or confidential information. We avoid asking for specific details about companies, products, or financial performance that could be considered material non-public information.

• We don’t discuss specific securities or investments: insightsZ refrains from asking the expert about specific stocks, companies, or investment opportunities that could be considered material non-public information. We focus on keeping the conversation focused on industry trends, market dynamics, and general insights.

• Respect confidentiality agreements: If the expert is bound by confidentiality agreements or insider trading regulations, we stay mindful of their limitations and avoid putting them in a position where they may inadvertently disclose material non-public information.

• Conduct interviews in a professional manner: We maintain a professional and ethical approach throughout the interview process. We stay transparent about our intentions, respect the expert's expertise, and ensure that the conversation remains focused on general insights and industry trends.